title: Drug points: Dysgeusia and burning mouth syndrome by eprosartan.
authors.affiliation: Fundacia Institut Catala de Farmacologia, Servei de Farmacologica Clinica Hospital, Universitari Vall d'Hebron, 08035, Barcelona, Spain.
authors.forename: Xavier
authors.initials: X
authors.lastname: Castells
authors.forename: Isidre
authors.initials: I
authors.lastname: Rodoreda
authors.forename: Consuelo
authors.initials: C
authors.lastname: Pedrós
authors.forename: Gloria
authors.initials: G
authors.lastname: Cereza
authors.forename: Joan-Ramon
authors.initials: JR
authors.lastname: Laporte
mesh_terms: D000179:Acrylates / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002054:Burning Mouth Syndrome / Q000139:chemically induced*; D004408:Dysgeusia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008875:Middle Aged; D013876:Thiophenes
chemical_list: D000179:Acrylates; D000959:Antihypertensive Agents; D007093:Imidazoles; D013876:Thiophenes; C068373:eprosartan